Reading the annual reports…
First time this company is opened: we are analysing its official reports. This can take up to a minute; after that the page loads instantly.
First time this company is opened: we are analysing its official reports. This can take up to a minute; after that the page loads instantly.
A · NYSE · United States · Laboratory Analytical Instruments
In shortAGILENT TECHNOLOGIES, INC. is profitable, generates cash and carries moderate debt, with revenue growing (+6.7% last year).
Financial health
Strong
Built from five areas over the last five annual reports. Tap an area to see the figures behind it.
| Operating marginShare of each sale left after running the business, before interest and tax. | 21.3% | 88/100 |
|---|---|---|
| Net marginShare of each sale left as profit after every cost, interest and tax. | 18.8% | 95/100 |
| Return on equityProfit earned on the money shareholders put in. Above 15% is strong. | 20.6% | 100/100 |
| Return on invested capitalProfit earned on all the capital used (equity and debt). Above 10% usually means a real competitive edge. | 13.3% | 89/100 |
Weight in the score: 25%
| Current ratioShort-term assets divided by short-term debts. Below 1 can mean tight cash. | 1.96× | 96/100 |
|---|---|---|
| Debt / equityDebt compared with the shareholders' stake. Above 2 is heavily indebted. | 0.50× | 83/100 |
| Net debt / EBITDAYears of operating profit needed to repay net debt. Below 2 is comfortable. | 0.89× | 89/100 |
| Interest coverageHow many times operating profit covers interest. Below 2 is risky. | 13.21× | 100/100 |
| Altman Z''Bankruptcy-risk model. Above 2.6 safe, below 1.1 distress. | 3.48 | 61/100 |
Weight in the score: 25%
| Free cash flow marginCash left from each sale after investments. The money that can pay dividends or reduce debt. | 16.6% | 86/100 |
|---|---|---|
| Free cash flow / net incomeHow much accounting profit turns into real cash. Near 1 or above is healthy. | 0.88× | 73/100 |
| Years with positive free cash flow (last 5) | 5 of 5 | 100/100 |
Weight in the score: 20%
| Profitable years (last 5) | 5 of 5 | 100/100 |
|---|---|---|
| Years of revenue decline (last 5) | 2 of 5 | 33/100 |
| Revenue growth volatility | 8.8% | 78/100 |
| Operating margin volatility | 1.5% | 95/100 |
Weight in the score: 20%
| Revenue growth, 3-year average | 0.5% | 19/100 |
|---|---|---|
| EPS growth, 3-year average | 3.0% | 40/100 |
Weight in the score: 10%
Fiscal year 2025 · change vs prior year
Annual figures as reported. Hover a bar or point for the exact value.
5 older years available with the 10-year history. Essential plan, from €8.25/month →
The last 5 fiscal years from the company's annual reports.
USD millions; negative values in parentheses.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | 6,319 | 6,848 | 6,833 | 6,510 | 6,948 |
| Cost of revenue | 2,912 | 3,126 | 3,368 | 2,975 | 3,305 |
| Gross profit | 3,407 | 3,722 | 3,465 | 3,535 | 3,643 |
| Research & development | 441 | 467 | 481 | 479 | 455 |
| Selling, general & admin | 1,619 | 1,637 | 1,634 | 1,568 | 1,709 |
| Operating income | 1,347 | 1,618 | 1,350 | 1,488 | 1,479 |
| Interest expense | 81 | 84 | 95 | 96 | 112 |
| Pre-tax income | 1,360 | 1,504 | 1,339 | 1,521 | 1,435 |
| Income tax | 150 | 250 | 99 | 232 | 132 |
| Net income | 1,210 | 1,254 | 1,240 | 1,289 | 1,303 |
| Diluted EPS | $3.94 | $4.18 | $4.19 | $4.43 | $4.57 |
| Diluted shares (millions) | 307 | 300 | 296 | 291 | 285 |
5 older years available with the 10-year history. Essential plan, from €8.25/month →
3.48 Safe zone
Estimates bankruptcy risk from working capital, retained earnings, operating profit and equity. Above 2.6 is considered safe, below 1.1 signals distress.
5/9
Nine yes-or-no tests on profitability, debt, liquidity and efficiency versus the prior year. 7 to 9 is strong, 0 to 3 is weak.
All figures: SEC EDGAR. Ratios and scores are computed by Scorvest (see how it works). Information only, not investment advice. How it works
Latest annual report: Jul 31, 2026 · Data updated Sep 1, 2026